Enliven Therapeutics, Inc.
ELVN·NasdaqGS
40.84−0.14 (−0.34%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours40.840.00 (0.00%)Oct 12, 4:01 PM EDT
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close40.98
Open40.67
Day range40.5041.41
52-week range14.7962.32
Off day high−1.38%
Off 52-week high−34.47%
Volume579.82K
Avg. volume (3M)1.14M
Market cap2.99B
EPS (TTM)-1.67
Forward P/E-17.35
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding73.27M
Short interest—
Earnings dateNov 11, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| ELVN | AVBP | TNGX | IDYA | SNDX | CADL | |
|---|---|---|---|---|---|---|
| Market cap | 2.99B | 811.61M | 4.08B | 3.48B | 1.48B | 748.35M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -17.3 | -4.2 | -14.3 | -9.0 | -19.4 | -15.6 |
| Price/book | 3.3 | 2.2 | 8.9 | 2.9 | 97.9 | 5.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +98.16% | −17.70% | +177.82% | +34.89% | +11.78% | +53.63% |
| Today | −0.34% | −1.61% | +1.51% | −0.14% | −2.59% | −1.61% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ELVN news ›No recent coverage in the 4Search index.
From articles in the 4Search news index.